HIMS
PYXS icon

Hager Investment Management Services’s Pyxis Oncology PYXS Stock Holding History

Hager Investment Management Services’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.3K Buy
+5,000
New +$7.54K ﹤0.01% 246

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hager Investment Management Services's PYXS Position: Q1 2026 in Review

Hager Investment Management Services opened a new position in Pyxis Oncology (PYXS) in Q1 2026: 5,000 shares worth $7.3K. The stake represents ﹤0.01% of the portfolio and ranks #246 among its holdings.

78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • Hager Investment Management Services held 5,000 shares of Pyxis Oncology worth $7.3K as of Q1 2026.
  • Pyxis Oncology was a new Hager Investment Management Services position in Q1 2026.
  • Pyxis Oncology made up ﹤0.01% of Hager Investment Management Services's portfolio in Q1 2026, its #246 holding.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on Hager Investment Management Services's 13F filing for Q1 2026, filed 12 May 2026.